BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT04239157-completion@plaintrial.com
DTSTAMP:20261027T233909Z
DTSTART;VALUE=DATE:20261231
SUMMARY:A Phase II\, Open-Label\, Study of Subcutaneous Canakinumab\, an An
 ti-IL-1β Human Monoclonal Antibody\, for Patients With Low or Int-1 Risk 
 IPSS/IPSS-R Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia 
 — estimated completion date
DESCRIPTION:Recruiting. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT04239157
URL:https://plaintrial.com/trial/NCT04239157
END:VEVENT
END:VCALENDAR